amlycas
PROTHENA THERAPEUTİCS LİMİTED
Süreç
- Başvuru 4 Nisan 2018
- Bültende yayın Resmî Marka Bülteni 307 · 27 Ağustos 2018
- İtiraz penceresi (2 ay) Son gün 27 Ekim 2018 · kapandı
- Tescil Tescil no 2018 61166· Gazete 457 (31 Ocak 2019)
- Yenileme Koruma 10 yıl: yenileme tarihi Nisan 2028 (son 6 ay içinde başvurulur).
Resmî süreler ve işlemler için TÜRKPATENT esastır; Nomist bilgilendirme aracıdır.
Sınıflar ve kapsam
Mal ve hizmet listesi
Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of autoimmune, metastatic, hematologic, oncologic, ocular and neurologic diseases, conditions and disorders; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders associated with misfolded proteins; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders affecting the central nervous system; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of amyloidosis, psoriasis, psoriatic arthritis, rheumatoid arthritis, dermatitis, host and graft rejections, Alzheimer's and Parkinson's-disease associated neuropsychiatric disorders, insulin resistance, metabolic syndrome and diabetes.
Aynı bültende benzer başvurular
Bülten 307 içindeki 213 aynı-sınıf başvuru arasında Nomist'in benzerlik algoritmasına takılan yok.